Resveratrol Inhibits Colorectal Cancer Cell Tumor Property by Activating the miR-769-5p/MSI1 Pathway-Reference-Cited by-同舟云学术

Resveratrol Inhibits Colorectal Cancer Cell Tumor Property by Activating the miR-769-5p/MSI1 Pathway

Published:2024-05-21 Issue: Volume: Page:
ISSN:1073-6085
Container-title:Molecular Biotechnology
language:en
Short-container-title:Mol Biotechnol

Author:

Liu Hongchang,Zhang Liangliang,Hao Liangliang,Fan Dingwen^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12033-024-01167-w.pdf

Reference36 articles.

1. Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. A Cancer Journal for Clinicians, 68(1), 7–30.

2. Scholefield, J. H., & Steele, R. J. (2002). Guidelines for follow up after resection of colorectal cancer. Gut, 51(Suppl 5), V3-5.

3. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: A systematic analysis for the global burden of disease study 2019. The Lancet Gastroenterology & Hepatology. 2022, 7(7), 627–647.

4. Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., Ogunbiyi, O. J., Azevedo, E. S. G., Chen, W. Q., Eser, S., Engholm, G., Stiller, C. A., Monnereau, A., Woods, R. R., Visser, O., … Coleman, M. P. (2018). Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England)., 391(10125), 1023–1075.

5. Balacescu, O., Sur, D., Cainap, C., Visan, S., Cruceriu, D., Manzat-Saplacan, R., Muresan, M. S., Balacescu, L., Lisencu, C., & Irimie, A. (2018). The impact of miRNA in colorectal cancer progression and its liver metastases. International Journal of Molecular Sciences, 19(12), 3711.